WSJ Brings Some Objectivity to the Media & Asks What the FDA’s Agenda is with Ivermectin
In a breath of fresh air, a mainstream media opinion piece asks why the U.S. Food and Drug Administration (FDA) is denigrating a perfectly safe…
Category: News
Too Many Lupus Patients Precluded from Clinical Trials Due to Overly Complex Inclusion Criteria
Much like in the therapeutic area of oncology, where overly stringent study protocol inclusion and exclusion criteria make it very difficult for large numbers of…
Is Moderna Overdosing in the KidCove Clinical Trial?
The Moderna Kidcove trial tests the efficacy of the vaccines under Emergency Use Authorization (EUA) in children. As we already know, NCT04649151 was used to…
Cerba Research Awarded NIH Contract for Central Lab Services
Cerba Research, a contract services venture, today announced it was awarded a five-year contract for Clinical Central Laboratory Services from the National Institute of Allergy…
Mycovia Pharmaceuticals Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals, Inc. (Mycovia), an emerging biopharmaceutical company dedicated to recognizing and empowering those living with unmet medical needs by developing novel therapies, today announced…
Vietnam Making Moves to Standardize Trial Site Quality Across the Country with Aim of Becoming Research Hub in the Future
Recently, a team from both government and elite academic research centers in Vietnam sought to assess the capacity of local healthcare centers to serve as…
UT Dallas Researchers Progress Molecular Sweat Detection Device to Identify COVID-19 Immune Response: Headed to Clinical Trials
A team of scientists at the University of Texas at Dallas developed a wearable sensor that can monitor the human body’s immune response to COVID-19…
Study: DexCom’s Continuous Glucose Monitor Superior to Antiquated Finger Prick Across the Board
175 patients with poorly controlled diabetes were part of a 15-center study that investigated whether continuous glucose monitoring, as compared to blood glucose meter monitoring…
Major Medical Journal Editor Raises Concerns about mRNA-based Vaccines
On May 28, TrialSite reported on information regarding mRNA vaccine safety revealed by a freedom of information act (FOIA) request filed by a group of Canadian physicians who were…
Omaha Doctor Sees Tremendous Success with Ivermectin as Early Treatment Against COVID-19
Physicians from around the United States continue to emerge, going public with their declaration of the benefits of ivermectin as an early onset, mild-to-moderate stage…